Syndax Pharmaceuticals, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 64.9M | 68.5M | 45.9M | 38.0M | 20.0M | 7.7M | 12.5M | 3.5M |
| Cost of Goods Sold | 2.6M | -1.6M | 2.1M | 1.3M | 885K | 0 | 0 | 0 |
| Gross Profit | 62.2M | 70.1M | 43.8M | 36.7M | 19.2M | 7.7M | 12.5M | 3.5M |
| R&D Expenses | 58.8M | 78.6M | 56.3M | 62.2M | 61.6M | 65.5M | 71.0M | 48.7M |
| Operating Expenses | 96.4M | 132.6M | 101.2M | 106.0M | 102.9M | 104.0M | 102.1M | 77.7M |
| Operating Income | -34.2M | -62.5M | -57.4M | -69.4M | -83.8M | -96.4M | -89.6M | -74.2M |
| Other Income / Gains | -8.5M | -5.5M | -3.3M | -2.5M | -1.1M | 2.2M | 5.5M | 6.2M |
| Net Income | -42.7M | -68.0M | -60.7M | -71.8M | -84.8M | -94.2M | -84.1M | -68.1M |
| EPS (Diluted) | -0.49 | -0.78 | -0.70 | -0.83 | -0.99 | -1.10 | -0.98 | -0.80 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.959 | 1.023 | 0.954 | 0.966 | 0.956 | 1.00 | 1.00 | 1.00 |
| General And Administrative Expenses | 37.6M | 49.9M | 44.9M | 43.8M | 41.0M | 37.7M | 31.1M | 29.1M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 37.6M | 49.9M | 44.9M | 43.8M | 41.0M | 37.7M | 31.1M | 29.1M |
| Other Expenses | 0 | 4.0M | 0 | 0 | 247K | 826K | 0 | 0 |
| Cost And Expenses | 99.1M | 131.0M | 103.3M | 107.3M | 103.8M | 104.0M | 102.1M | 77.7M |
| Interest Income | 3.6M | 9.6M | 5.3M | 6.0M | 7.2M | 7.1M | 5.4M | 6.3M |
| Interest Expense | 11.8M | 52.7M | 8.3M | 7.9M | 8.1M | 4.8M | 23K | 45K |
| Depreciation And Amortization | 4K | 3K | 3K | 0 | 9.1M | 0 | 2K | 3K |
| Ebitda | -30.8M | -15.3M | -52.4M | -64.0M | -83.8M | -89.4M | -84.1M | -68.0M |
| Ebitdaratio | -0.475 | -0.224 | -1.143 | -1.686 | -4.179 | -11.636 | -6.728 | -19.433 |
| Operating Income Ratio | -0.527 | -0.913 | -1.252 | -1.827 | -4.179 | -12.548 | -7.166 | -21.205 |
| Income Before Tax | -42.7M | -68.0M | -60.7M | -71.8M | -84.8M | -94.2M | -84.1M | -68.1M |
| Income Before Tax Ratio | -0.658 | -0.993 | -1.324 | -1.893 | -4.233 | -12.262 | -6.73 | -19.447 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -0.658 | -0.993 | -1.324 | -1.893 | -4.233 | -12.262 | -6.73 | -19.447 |
| Epsdiluted | -0.49 | -0.78 | -0.70 | -0.83 | -0.99 | -1.10 | -0.98 | -0.80 |
| Weighted Average Shs Out | 86.6M | 86.6M | 86.6M | 86.3M | 85.6M | 85.8M | 85.4M | 85.3M |
| Weighted Average Shs Out Dil | 86.6M | 86.6M | 86.6M | 86.3M | 85.6M | 85.8M | 85.4M | 85.3M |